Brinzolamide/Brimonidine Fixed Combination: Simplifying Glaucoma Treatment Regimens
Abstract Introduction To simplify the medical treatment of glaucoma for patients on multiple drops by introducing brinzolamide/brimonidine tartrate fixed combination (BBFC) ophthalmic suspension 1%/0.2% (SIMBRINZA®; Alcon Laboratories, Inc., Fort Worth, TX, USA) to the drop regimen and to establish...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Adis, Springer Healthcare
2018-10-01
|
| Serie: | Ophthalmology and Therapy |
| Soggetti: | |
| Accesso online: | http://link.springer.com/article/10.1007/s40123-018-0150-x |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|